Among the most promising investigational molecules is the High-Dose Synedica Retatrutide Pen, a convenient delivery system containing Retatrutide, an advanced triple receptor agonist that activates GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and Glucagon receptors simultaneously. Call Us: +1 (215) 915-1716